【结 构 式】 |
【分子编号】40998 【品名】tert-butyl (2S,4R)-2-(azidomethyl)-4-[([1,1'-biphenyl]-2-ylmethyl)(isobutyl)amino]-1-pyrrolidinecarboxylate 【CA登记号】 |
【 分 子 式 】C27H37N5O2 【 分 子 量 】463.62328 【元素组成】C 69.95% H 8.04% N 15.11% O 6.9% |
合成路线1
该中间体在本合成路线中的序号:(X)Treatment of the alcohol (I) with MsCl in the presence of TEA, followed by treatment with NaN3 in presence of HMPA yields the azide derivative (II). This species reacts with isobutyraldehide under reductive conditions (H2, Pd/C) leading to the substituted amine (III) which will be further substituted by reaction with the bromine derivative (IV) in basic conditions to yield derivative (V). Derivative (V) can also be obtained by following this pathway: Reduction of azide (II) with PPh3 in THF followed by reaction with refluxing water yields amine derivative (VI). This derivative is reductocondensed with the aldehyde (VII) and NaBH4 providing the substituted amine (VIII). This amine is further substituted by reductocondensation with isobutyraldehyde and NaCNBH3. Reduction of the substituted amine (V) with LiBH4 or LiAlH4 affords the alcohol (IX), which is converted into the corresponding azide (X) as already reported for (II). Reduction of azide (X) by means of SnCl2·2H2O/NaOH in water yields amine (XI), which is condensed with acid (XII) in presence of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrocloride (WSC) and HOBt. Elimination of the protecting group Boc with HCl provides derivative (XIII), which is finally condensed with the aromatic acid (XIV) in the same conditions described for the coupling of (XI) with (XII).
【1】 Nishi, K.; Seno, K.; Okuno, T.; et al.; Pyrrolidine inhibitors of human cytosolic phospholipase A2. J Med Chem 2000, 43, 6, 1041. |
【2】 Seno, K.; Ohtani, M.; Watanabe, F. (Shionogi & Co. Ltd.); Pyrrolidine derivs. having phospholipase A2 inhibitory activity. EP 0976748; WO 9833797 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(A) | 13226 | 2-Methylpropanal; Isobutyraldehyde | 78-84-2 | C4H8O | 详情 | 详情 |
(I) | 15783 | 1-(tert-butyl) 2-methyl (2S,4S)-4-hydroxytetrahydro-1H-pyrrole-1,2-dicarboxylate | C11H19NO5 | 详情 | 详情 | |
(II) | 15785 | 1-(tert-butyl) 2-methyl (2S,4R)-4-azidotetrahydro-1H-pyrrole-1,2-dicarboxylate | C11H18N4O4 | 详情 | 详情 | |
(III) | 40992 | 1-(tert-butyl) 2-methyl (2S,4R)-4-(isobutylamino)-1,2-pyrrolidinedicarboxylate | C15H28N2O4 | 详情 | 详情 | |
(IV) | 40993 | 2-(bromomethyl)-1,1'-biphenyl | C13H11Br | 详情 | 详情 | |
(V) | 40994 | 1-(tert-butyl) 2-methyl (2S,4R)-4-[([1,1'-biphenyl]-2-ylmethyl)(isobutyl)amino]-1,2-pyrrolidinedicarboxylate | C28H38N2O4 | 详情 | 详情 | |
(VI) | 15786 | 1-(tert-butyl) 2-methyl (2S,4R)-4-aminotetrahydro-1H-pyrrole-1,2-dicarboxylate | C11H20N2O4 | 详情 | 详情 | |
(VII) | 40996 | [1,1'-biphenyl]-2-carbaldehyde | C13H10O | 详情 | 详情 | |
(VIII) | 40995 | 1-(tert-butyl) 2-methyl (2S,4R)-4-[([1,1'-biphenyl]-2-ylmethyl)amino]-1,2-pyrrolidinedicarboxylate | C24H30N2O4 | 详情 | 详情 | |
(IX) | 40997 | tert-butyl (2R,4R)-4-[([1,1'-biphenyl]-2-ylmethyl)(isobutyl)amino]-2-hydroxy-1-pyrrolidinecarboxylate | C26H36N2O3 | 详情 | 详情 | |
(X) | 40998 | tert-butyl (2S,4R)-2-(azidomethyl)-4-[([1,1'-biphenyl]-2-ylmethyl)(isobutyl)amino]-1-pyrrolidinecarboxylate | C27H37N5O2 | 详情 | 详情 | |
(XI) | 40999 | tert-butyl (2S,4R)-2-(aminomethyl)-4-[([1,1'-biphenyl]-2-ylmethyl)(isobutyl)amino]-1-pyrrolidinecarboxylate | C27H39N3O2 | 详情 | 详情 | |
(XII) | 41000 | (E)-3-[4-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]-2-propenoic acid | C13H9NO4S | 详情 | 详情 | |
(XIII) | 41001 | tert-butyl (2S,4R)-4-[([1,1'-biphenyl]-2-ylmethyl)(isobutyl)amino]-2-[[((E)-3-[4-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl]-2-propenoyl)amino]methyl]-1-pyrrolidinecarboxylate | C40H46N4O5S | 详情 | 详情 | |
(XIV) | 41002 | 2-(2,4-difluorobenzoyl)benzoic acid | C14H8F2O3 | 详情 | 详情 |